about
The emerging role of viral vectors as vehicles for DMD gene editingGenome Engineering with TALE and CRISPR Systems in NeuroscienceGenome-editing Technologies for Gene and Cell TherapyCRISPR/Cas9 and cancer targets: future possibilities and present challengesAdenoviral vectors encoding CRISPR/Cas9 multiplexes rescue dystrophin synthesis in unselected populations of DMD muscle cells.Harnessing the Prokaryotic Adaptive Immune System as a Eukaryotic Antiviral Defense.Gene Editing for Treatment of Neurological Infections.Selection-free gene repair after adenoviral vector transduction of designer nucleases: rescue of dystrophin synthesis in DMD muscle cell populations.Salient Features of Endonuclease Platforms for Therapeutic Genome EditingNon-viral delivery of genome-editing nucleases for gene therapy.Genome Editing Techniques and Their Therapeutic Applications.Human lung ex vivo infection models.Novel AIDS therapies based on gene editing.Delivery technologies for genome editing.Localization and pneumococcal alteration of junction proteins in the human alveolar-capillary compartment.Sendai virus, an RNA virus with no risk of genomic integration, delivers CRISPR/Cas9 for efficient gene editingViral Vectors, Engineered Cells and the CRISPR Revolution.The evolution of CRISPR/Cas9 and their cousins: hope or hype?In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease.CRISPR/Cas9-Based Safe-Harbor Gene Editing in Rhesus iPSCs.Delivering CRISPR: a review of the challenges and approachesIn vivo methods for acute modulation of gene expression in the central nervous systemTransient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene KnockoutDNA, RNA, and Protein Tools for Editing the Genetic Information in Human Cells
P2860
Q26746647-0DD4A7BA-C515-4182-8F0E-D26091137A28Q26752488-B5FCDCD7-31BA-412F-8310-40721D26C911Q26769662-C41CF49F-0490-41B1-BED8-B167C972B375Q26769907-09E3ECEB-1E84-4CC9-9670-2F84F7D881EDQ34047674-ACAECDDE-0FAD-40A8-8F54-32386FF7F431Q36730743-5B609A13-CD81-4B9A-B39B-A0EC939A5EDAQ37136471-80FB31DB-5F3D-4405-B228-989514481932Q38531000-3B68A8A5-4F6D-42D9-B2EB-2702DF3FCA08Q38706622-BD4FA350-69A2-4ADC-AA94-DB58F4280079Q38802151-56A6576A-18DF-4C82-B511-875C7B1AB902Q38991325-D33409AC-486D-4A4F-9D3C-9F4E27F9C082Q39045096-D42D18DE-5D47-4A67-926A-43890A539114Q39140209-ADA08E7D-7C46-4056-AB19-D68148CC554EQ39197557-C79C48E8-80E1-4138-8279-877AD2FF84C3Q40313722-FE345D66-DC04-41D0-B374-DEBA00227135Q40547669-57CA1EC6-65F5-43E5-9F51-2F410BED04E5Q45874356-D3950FD4-BD09-4466-AD19-D5B859E172D2Q47552046-8E623EAC-90DE-477D-BFAC-D95333A110E7Q47553772-866F52CB-5B3F-4AE1-9A3C-264CCBF0F1C5Q47579618-FE4697D9-05E5-48D9-81F7-C4FFE98B9768Q56610090-DD61B967-29C1-4B08-9581-DFCE7175115FQ57020987-01321416-321E-4063-8EFD-819703680B0FQ57493531-5B876B8A-57E3-44CF-9F5C-52735463364DQ58800372-61A84692-8D2F-4F85-87A7-259E5B6D8665
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Engineered Viruses as Genome Editing Devices
@ast
Engineered Viruses as Genome Editing Devices
@en
Engineered Viruses as Genome Editing Devices
@nl
type
label
Engineered Viruses as Genome Editing Devices
@ast
Engineered Viruses as Genome Editing Devices
@en
Engineered Viruses as Genome Editing Devices
@nl
prefLabel
Engineered Viruses as Genome Editing Devices
@ast
Engineered Viruses as Genome Editing Devices
@en
Engineered Viruses as Genome Editing Devices
@nl
P2860
P921
P3181
P356
P1433
P1476
Engineered Viruses as Genome Editing Devices
@en
P2093
Manuel A F V Gonçalves
Xiaoyu Chen
P2860
P304
P3181
P356
10.1038/MT.2015.164
P407
P577
2016-03-01T00:00:00Z